GGrantIndex
← Search

NSABP B23--Adriamycin/cyclophosamide/methotrexate/fluorouracil in breast cancer

$0M01FY2000RRNIH

University Of Connecticut Sch Of Med/Dnt, Farmington CT

Investigators

Linked publications & trials

View original record on NIH RePORTER →
NSABP B23--Adriamycin/cyclophosamide/methotrexate/fluorouracil in breast cancer · GrantIndex